Prebiotic Effect on Metabolites in Crohn's Disease

Metabolite Profiling of the Impact of Oligofructose Enriched Inulin in Crohn's Disease Patients

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01487759

Enrollment

Registered

2011-12-07

Start date

2008-03-31

Completion date

2009-07-31

Last updated

2011-12-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Crohn Disease

Brief summary

The purpose of this study is to investigate the influence of the prebiotic oligofructose enriched inulin on the metabolite pattern in Crohn's disease patients.

Interventions

DIETARY_SUPPLEMENTOligofructose enriched inulin

DIETARY_SUPPLEMENTMaltodextrin

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

BASIC_SCIENCE

Masking

TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* crohn's disease

Exclusion criteria

* severe crohn's disease (harvey bradshaw index \>12) * pregnancy * history of colectomy * use of antibiotics 4-wks before start of the study * use of sulfapyridine * use of commercially available prebiotics and probiotics

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026